McPherron will oversee strategy for the company’s operations, manufacturing, regulatory, clinical and quality teams.
Prior to joining Orthofix, McPherron served as senior VP of clinical services and integration at Globus Medical, where she was responsible for strategic initiatives to drive growth and enhance profitability. She also led the integration planning and execution of the merger between Globus Medical and NuVasive.
“We are pleased to have Aviva join our leadership team,” said Orthofix President and CEO Massimo Calafiore. “Her experience and background will be an asset to our strong operations, clinical, regulatory and quality teams to help drive strategies that deliver operational efficiencies and gross margin improvements, both of which are critical to achieving the value of our merger.”
McPherron was NuVasive’s chief transformation officer prior to the merger. In that role, she led the strategy to transform the commercial and operational processes, portfolio and back-office organization to drive profitability. She has also held a variety of leadership roles in the technology and defense industries.
“The merger of Orthofix and SeaSpine has the company well-positioned for growth and success, and I am excited to be joining this talented team,” said McPherron. “I look forward to working with the team to foster better coordination and optimization across the company’s operational processes to ensure the best quality products are available for surgeons and their patients.”
This appointment follows a series of executive moves from Orthofix in recent months. Last week, the company appointed Julie Dewey as its new chief investor relations and communications officer. Max Reinhardt was also named president of the company’s global spine business.
Last fall, the company terminated a trio of executives with cause. Orthofix cut ties with CEO Keith Valentine, CFO John Bostjancic and chief legal officer Patrick Keran following an investigation.
The company then picked former LimaCorporate CEO Massimo Calafiore as its next CEO in November. In January, Julie Andrews took over as CFO, followed by the appointment of Andres Cedron as chief legal officer in April.
